摘要
目的:介绍李素云教授辨证论治支气管扩张的临床经验。方法:从病因病机、治则治法、分期施治、内外结合、典型病例等方面对其辨治经验进行了总结。结果:李教授认为支气管扩张病机气虚为本,痰瘀互结为标,临床施治应补肺益气、祛痰化瘀,权衡标本主次之变化,止血是其治疗重点,临床施治多从急性发作期和缓解期分期论治,灵活化裁。并注重外治法和中医传统疗法在临床施治中的应用,内外结合,临床疗效显著。结论:李教授认为支气管扩张是一种反复发作、缠绵难愈的难治性疾病,无论急性发作期还是缓解期,肺虚均是其发病的根本原因。临床采用中医分期施治,标本兼顾,气血同治,内外合治,取得了较好的临床疗效。
Objective：This article introduces Professor LI Su-yun′s experience on the treatment of Bronchiectasis（BCT） with syndrome differentiation and treatment.Methods：To summarizes the experience from the aspects of etiology and pathogenesis,therapeutic principle and methods,therapy staging,the essential etiopathogenesis,internal and external combination and typical cases and so on.Results：Professor Li holds that pathogenesis of bronchiectasis is qi deficiency as the fundamental cause and stagnation of phlegm and blood stasis as the secondary cause.The clinical treatment should be supplementing the lung and replenishing qi,removing the phlegm and resolving the stagnation and weighing the changes of fundamental and secondary factors.Hemostatic therapy is the key of treatment.Clinical differentiation and treatment is applied by classifying acute exacerbation and remission stage and modifying flexibly.And focus on the application of external therapy and traditional Chinese therapies in the clinical differentiation and treatment as well as internal and external integration has achieved significant clinical efficacy.Conclusion：Bronchiectasis is a recurring and intractable disease,which is hard to be cured.Whether for the acute exacerbation or remission,lung deficiency is the fundamental cause of the disease.Clinical use of staging treatment with Chinese medicine,covering both the fundamental and secondary factors and internal and external governance has achieved better clinical efficacy.
出处
《中医学报》
CAS
2011年第2期159-160,共2页
Acta Chinese Medicine
基金
郑州市科技研究与开发经费支持项目(编号:10LJRC172)
关键词
李素云
支气管扩张
中医药疗法
LI Su-yun
bronchiectasis
therapy with traditional Chinese medicine
